CASEY CULPEPPER: Open Payments
NPI 1487382859 · PRATTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 109 payments from 23 companies in 2025. Trend: 2023 $193 · 2024 $1,557 · 2025 $2,297
Food & beverage: $2,297
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $384 |
| PFIZER INC. | 17 | $320 |
| Otsuka America Pharmaceutical, Inc. | 9 | $191 |
| GlaxoSmithKline, LLC. | 4 | $182 |
| Neurocrine BioSciences, Inc. | 8 | $178 |
| Novo Nordisk Inc | 9 | $169 |
| Exact Sciences Corporation | 7 | $121 |
| ABBVIE INC. | 5 | $113 |
| Sumitomo Pharma America, Inc. | 7 | $107 |
| Lilly USA, LLC | 6 | $102 |
Products named: REXULTI, NURTEC ODT, BREZTRI, INGREZZA, ELIQUIS, AIRSUPRA, GEMTESA, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
